Trials / Unknown
UnknownNCT01450150
Transcranial Direct Current Stimulation as an Augmenting Intervention for Major Depression
Transcranial Direct Current Stimulation (tDCS) as an Augmenting Intervention for Treatment-Resistant Major Depression: A Randomized, Double-Blind and Sham-Controlled Trial
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Douglas Mental Health University Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Transcranial direct current stimulation (tDCS) is a noninvasive method to activate or de-activate neurons in superficial regions of the brain through the induction of weak electric currents in the brain tissue delivered by two scalp electrodes. Initial studies have shown tDCS to be effective for treating major depressive disorder (MDD), although there are negative trials in the specialized literature. One reason for these discrepant results might be that the duration of tDCS treatment in clinical trials to date (up to 2 weeks) is still insufficient to produce consistent clinical improvements. Thus, we intend to assess, in a sample of outpatients with MDD, whether a 3-week adjunctive course of active tDCS over the left dorsolateral prefrontal cortex is associated with a significant clinical improvement when compared to sham tDCS. The investigators hypothesize that subjects receiving active tDCS will present with significantly higher response and remission rates at weeks 3.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Direct Current Stimulation | 20-minute daily sessions of 2 mA tDCS for 15 days (Monday to Friday on three consecutive weeks) |
| DEVICE | Transcranial Direct Current Stimulation | The tDCS stimulator will be turned on for 30 seconds only, after which it will be gradually decreased and then turned off for the remainder of the 20-minute daily sessions for 15 days (Monday to Friday on three consecutive weeks). |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2011-10-12
- Last updated
- 2016-01-20
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01450150. Inclusion in this directory is not an endorsement.